作者: J. Timothy Baldwin, , John T. Watson
DOI: 10.1016/B978-0-323-56699-5.00001-2
关键词:
摘要: Abstract The mechanical circulatory support (MCS) devices of today trace their roots to ex-vivo studies in the 1930s, clinical application for heart-lung machine 1950s, and advent National Institutes Health Artificial Heart Program 1960s. Since then, MCS have evolved from large positive-displacement pumps with limited durability control consoles battery-powered continuous-flow rotary compact smart controllers that are small enough be implanted infants. progress made these has occurred as a result federal private funding leading various technological breakthroughs by talented dedicated interdisciplinary teams engineers, scientists, clinicians. While current provide therapy advanced stage heart failure patients routinely live five years or longer an device better quality life, adverse events such strokes infections still common. Further on specific goals overcome issues is needed benefit more realize full potential